hubXchange is proud to unveil its upcoming 2025 San Francisco Xchange event series, a premier week of peer-to-peer collaboration and scientific advancement. From AI in drug discovery to next-generation antibody therapeutics, advanced therapies, immunotherapies, MedTech strategy, and oligonucleotide development, the Xchange series delivers a focused, high-impact platform for executive-level knowledge sharing across the life sciences industry.

Taking place in September 2025 on the 17th, 18th, 22nd, 23rd, 25th & 26th at the DoubleTree by Hilton San Francisco Airport Hotel, these one-day, highly-curated events are designed to tackle today’s most pressing industry challenges through interactive roundtable discussions, 1:1 business meetings, and expert-led presentations.

 

Event Line-Up and Focus Areas:

• AI in Drug Discovery Xchange
  September 17, 2025
  Key topics: Data Quality, Target Identification, Lead Optimization, Drug Response Prediction, Ligand Modeling.
  Keynote: Mark Hahnel, Vice President of Open Research – Digital Science.

• Advanced Therapies Xchange
  September 18, 2025
  Key topics: Next-Gen Vectors, Gene Therapy CMC, Cell Therapy Development, Manufacturing.
  Keynote speakers include leaders from Senti Bio, Bayer, Avista Therapeutics, and AstraZeneca.

• Antibody Therapeutics Xchange
  September 22, 2025
  Key topics: Bi/Multispecifics, Formats & Scaffolds, ADC Payloads, AI-Assisted Antibody Engineering.
  Featuring speakers from 3T Biosciences, Rondo Therapeutics, Eli Lilly, and more.

• MedTech Strategy Xchange (New Launch)
  September 23, 2025
  Key topics: Regulatory Strategy, Device Engineering, Clinical Trial Design, Scalable Manufacturing.
  Industry experts from ReMinded, Aerin Medical, HiLight Surgical, and InterVene Medical lead the discussions.

• Immunotherapies Xchange
  September 25, 2025
  Key topics: Immunogenicity, Translational Immunology, Clinical Development, Immune Regulation.
  Featuring expert contributions from Astellas Gene Therapies, Genentech, and Roche.

• Oligonucleotides & Peptides Xchange
  September 26, 2025
  Key topics: Innovation in Therapeutic Modalities, Oligo & Peptide CMC, Regulatory Strategy.
  Speakers from Ultragenyx, SMSbiotech, Eolo Pharmaceuticals, and Avirmax will be sharing insights.

 

Why Attend hubXchange?

hubXchange is not your typical conference.

We deliver executive-level roundtables called Xchanges—highly-interactive, topic-driven forums where senior decision-makers connect directly with industry innovators and peers to share strategies, validate ideas, and find real-world solutions.

Our USPs include:

• Intimate, focused discussions with senior-level experts—no exhibition halls or generic presentations

• Curated, personalized agendas and pre-booked 1:1 meetings

• Complimentary attendance for qualified delegates

• One-day format—maximum impact, minimal time commitment

• Access to global leaders in pharma, biotech, MedTech, and beyond

As the industry shifts toward more complex modalities, AI-led innovation, and personalized therapies, hubXchange provides a much-needed space for actionable dialogue and strategic alignment.

 

Comment from Leadership

“With the San Francisco 2025 series, we’re bringing together the brightest minds across biopharma and MedTech to tackle the challenges that matter most. Our Xchanges are designed to spark meaningful conversations, real-world solutions, and enduring partnerships. We’re proud to create a space where science, strategy, and innovation intersect.”
— Clarence Maguire-Swartz, Founder & Managing Director, hubXchange

 

About hubXchange

With over two decades of experience delivering life sciences conferences across North America and Europe, hubXchange is the global leader in executive-level networking for the pharmaceutical, biotech, and MedTech industries.

Our mission is simple: to accelerate progress in life sciences by creating the right conversations in the right setting with the right people.

We foster communities of innovation through our Xchange format, which brings together scientific leaders to share ideas, solve challenges, and drive meaningful outcomes.

 

Secure your complimentary place now and be part of the conversation that shapes the future of life sciences.

 

AI in Drug Discovery | 17th Sep 2025 | https://bit.ly/AI-SF-25-LI

Advanced Therapies | 18th Sep 2025 | https://bit.ly/ADT-SF-25-LI

Antibody Therapeutics | 22nd Sep 2025 | https://bit.ly/AbTx-SF-25-LI

MedTech Strategy | 23rd Sep 2025 | https://bit.ly/MTS-SF-25-LI

Immunotherapies | 25th Sep 2025 | https://bit.ly/ImT_SF_25_LI

Oligonucleotide & Peptides | 26th Sep 2025 | https://bit.ly/ONP-SF-25-LI

 

 

Follow us on LinkedIn: hubXchange LinkedIn
hubXchange – Where science meets strategy, and collaboration drives discovery.